• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Episode 17 - Evolving Guidelines for the Treatment of Cardiometabolic Events

Video

As guidelines to treat the risk factors of cardiovascular disease continue to evolve, Michael Weber, MD, explains how new editions of lipid, diabetes, and hypertension guidelines continue to improve patient care.

Dr Weber explains that we should not expect to see major changes as new treatment guidelines continue to develop, however, since last published several years ago, these guidelines are helpful because they are based on evidence, which is the basis to a good set of guidelines.

Dr Weber is confident in the decisions highlighted inside new guidelines by organized bodies such as the American Diabetes Association, National Kidney Foundation, and Joint National Committee because he feels that these bodies are putting a lot of effort into creating them.


Related Videos
Robert Zimmerman, MD
Leslie Fish, PharmD.
Ronesh Sinha, MD
Beau Raymond, MD
Dr Kevin Mallow, PharmD, BCPS, BC-ADM, CDCES
dr robert sidbury
Screenshot of Jennifer Vaughn, MD, in a Zoom video interview
Screenshot of Jennifer Vaughn, MD, in a Zoom video interview
James Robinson, PhD, MPH, University of California, Berkeley
James Robinson, PhD, MPH, University of California, Berkeley
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.